IOL Chemicals -; Pharma logs ~48% y-o-y decline in Q1FY23 PAT

11 Aug 2022 , 09:24 AM

IOL Chemicals and Pharmaceuticals Limited, a leading manufacturer of pharmaceutical (APIs) and specialty chemicals reported results for the first quarter ended June 30, 2022.

The company has reported a Total income of Rs570.20 crore in Q1FY23 as against Rs579.40 crore in the previous quarter, down by 1.6% sequentially. However, on a y-o-y basis, the company registered a growth of 8.78% against Rs524.20 crore in Q1FY22.

For Q1FY23, the company logged an EBITDA of Rs61.20 crore, up by 22.20% against Rs50.10 crore in the previous quarter. While on a y-o-y basis, EBITDA declined by 47.20% against Rs115.90 crore in Q1FY22.

Company achieved an EBITDA Margin of 10.70% in Q1FY23 as compared to 8.6% in Q4FY22.

IOL’s PAT in Q1FY23 stood at Rs34.90 crore as compared to Rs27.80 crore in Q4FY22, registering a growth of 25.50% yoy. PAT for Q1FY22 was reported at Rs67 crore, registering a decline of 47.91% yoy.

At around 9.27 AM, IOL Chemicals was trading at Rs354.30 up by Rs5.7 or 1.64% from its previous closing of Rs348.60 on the BSE. The scrip opened at Rs348.60.